Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.20.2
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
EXPENSES        
Research and development $ 1,103 $ 2,032 $ 2,644 $ 6,087
General and administrative 1,815 1,630 3,631 3,515
Total operating expenses 2,918 3,662 6,275 9,602
OTHER INCOME (EXPENSE)        
Interest income 3 41 45 103
Other expenses (7) (3) (12) (29)
Total other income (expense) (4) 38 33 74
Net loss (2,922) (3,624) (6,242) (9,528)
Comprehensive loss $ (2,922) $ (3,624) $ (6,242) $ (9,528)
Basic and diluted net loss per common share $ (1.68) $ (10.08) $ (3.79) $ (27.39)
Weighted average shares used in computation of basic and diluted net loss per common share 1,744,014 359,484 1,645,426 347,836